CLASS II ONGOING Device recall · Reported 20 May 2026 · FDA Enforcement Report

Zymutest Hia IgG, in vitro diagnostic Elisa kit recalled

Aniara Diagnostica is recalling Zymutest Hia IgG, in vitro diagnostic Elisa kit, distributed nationwide in the US. The recall was initiated on 1 Apr 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI-DI: 03663537018763; Lot Number: FD1265
Quantity recalled359 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2171-2026
FDA event ID
98754
Recalling firm
Aniara Diagnostica, West Chester, OH
Classification
Class II
Status
Ongoing
Recall initiated
1 Apr 2026
FDA classified
12 May 2026
Reported
20 May 2026
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

1 Apr 2026Recall initiated by company
12 May 2026Classified by FDA+41 days
20 May 2026Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Kits from lot FD1265 had been packaged on 17 October 2024 and put on the market with an outdated flyer (8 October 2024), containing incorrect values for the positive control.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

ZYMUTEST HIA IgG, in vitro diagnostic ELISA kit, Ref. RK040A

Where it was distributed

US Nationwide distribution in the states of CA, GA, MN, MO, NC, NM, NY, VA, WA, and WI

Nationwide CaliforniaGeorgiaMinnesotaMissouriNorth CarolinaNew MexicoNew YorkVirginiaWashingtonWisconsin

Questions about this recall

Why was it recalled?

Kits from lot FD1265 had been packaged on 17 October 2024 and put on the market with an outdated flyer (8 October 2024), containing incorrect values for the positive control.

Which lots are affected?

UDI-DI: 03663537018763; Lot Number: FD1265

Where was it sold?

US Nationwide distribution in the states of CA, GA, MN, MO, NC, NM, NY, VA, WA, and WI

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Aniara Diagnostica

All 11

Other Test Kits & Diagnostics recalls

All 2,656